Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic contains semaglutide, a medication originally developed for type 2 diabetes that has become widely used for weight management. Clinical trials show semaglutide users lose an average of 15–22% of body weight over 68 weeks. Understanding how this medication works helps you make an informed decision about whether it may fit your health goals.
How Semaglutide Works in Your Body
Semaglutide mimics glucagon-like peptide-1 (GLP-1), a natural hormone your gut releases after eating. When semaglutide binds to GLP-1 receptors in your brain, it activates regions that control hunger and satiety signals. This action reduces your appetite, slows how quickly your stomach empties, and increases feelings of fullness—all three changes working together to lower calorie intake without willpower alone.
The medication also improves how your body processes blood sugar, which can reduce energy crashes and cravings. Many patients report that food becomes less psychologically rewarding when taking semaglutide, making it easier to stick to smaller portions. These effects typically begin within days of starting treatment and build over the first 4–8 weeks as your dose increases.
Semaglutide Weight Loss Results and Clinical Evidence
The STEP trials, large randomized controlled studies, demonstrated that participants on semaglutide lost significantly more weight than those on placebo. After 68 weeks, semaglutide users achieved average weight loss of 15–22% of starting body weight, compared to 2–3% in the placebo group. Results were consistent across different body weights and metabolic backgrounds, suggesting semaglutide's effectiveness applies to a broad patient population.
Weight loss typically follows a predictable pattern: noticeable appetite reduction in weeks 1–2, steady loss of 1–2 pounds per week during months 2–6, and continued loss at a slower rate through month 12 and beyond. Individual results vary based on genetics, lifestyle, and adherence; the Precision Peptide Genetic Test offered by PlexusDx identifies your unique peptide-pathway predispositions to help predict response.
Compounded Semaglutide vs. Brand-Name Ozempic
Ozempic is the brand-name form of semaglutide manufactured by Novo Nordisk, but compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient. PlexusDx partners with licensed 503A compounding pharmacies to prepare semaglutide injections, ensuring pharmaceutical-grade quality and potency. Compounded semaglutide is not FDA-approved as a brand product, but the underlying compound is well-established and studied.
The primary advantages of compounded semaglutide are cost and access: PlexusDx offers it starting at $149 per month without requiring insurance, membership fees, or insurance approvals. Patients in all 50 states can access treatment, and HSA/FSA funds cover the cost. Your dose may need to go up as you progress through treatment. Your price won't—it remains flat regardless of dose level.
Getting Started with Semaglutide at PlexusDx
PlexusDx begins with a health assessment to confirm semaglutide is appropriate for you. Once approved, you receive injectable semaglutide shipped directly to your home with clear instructions for weekly self-injection. Most patients start at 0.25 mg weekly and increase every 4 weeks until reaching an effective dose, typically between 1 mg and 2.4 mg per week.
After your first month of treatment, PlexusDx offers the Precision Peptide Genetic Test for $99 as an add-on. This test maps 14 metabolic pathways and 150+ genetic insights related to peptide responses, including key variants in GLP1R, GIPR, FTO, and MC4R genes. Genetic insights help PlexusDx clinical staff personalize your dose escalation and predict your likely response trajectory, optimizing outcomes over time.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How quickly will I see weight loss results from semaglutide?
Most patients notice reduced hunger within 3–7 days and begin losing weight within 2–4 weeks. Average weekly loss during months 2–6 is 1–2 pounds, with results continuing through month 12. PlexusDx tracks your progress through ongoing clinical support to ensure your dose is optimized for your individual response.
What is the difference between Ozempic and semaglutide?
Ozempic is the brand name; semaglutide is the active ingredient inside it. PlexusDx offers compounded semaglutide prepared by licensed 503A pharmacies, delivering the same active compound as Ozempic but at a lower cost and with nationwide availability. Compounded semaglutide is not FDA-approved as a brand product, but semaglutide itself is a well-established, clinically studied medication.
Does PlexusDx require insurance to get semaglutide?
No. PlexusDx serves all 50 states with no insurance requirement, no membership fee, and no waiting for insurance approval. Compounded semaglutide starts at $149 per month and is HSA/FSA eligible. Your dose may increase over time, but your monthly price remains flat.
What are the common side effects of semaglutide?
Nausea is the most common side effect, especially during the first 1–2 weeks and after dose increases; it usually resolves within days to weeks. Other potential effects include constipation, vomiting, fatigue, and decreased appetite for certain foods. Most side effects are mild to moderate and decrease over time as your body adjusts. PlexusDx clinical staff monitors you throughout treatment and adjusts your plan if side effects become problematic.
Can the Precision Peptide Genetic Test predict how well semaglutide will work for me?
Yes. PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to GLP-1 therapies. The test maps 14 metabolic pathways and 150+ genetic insights, helping PlexusDx clinicians personalize your dose progression and predict your likely weight loss trajectory. The test costs $99 after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Weight Loss Medications: Does Ozempic Cause Eating Disorders?
Unveiling the Connection: Can You Take Ozempic® if You Have Asthma?